Bariatric surgery (BS) produces substantial weight loss, but long-term success arises from complex host–microbiome interactions. This prospective observational study evaluated whether baseline gut ecology predicts long-term fat-mass outcomes after BS and examined microbiome resilience and the influence of Mediterranean Diet (MedDiet) adherence over a 24-month period.
The study enrolled 85 patients with severe obesity undergoing bariatric surgery and 21 normal-weight healthy controls (HC). MedDiet adherence was measured before surgery using PREDIMED. Fecal microbiota composition was profiled by 16S-rRNA sequencing and fecal metabolomics by 1H-NMR spectroscopy. Samples and clinical data were collected at baseline and at 1, 6, and 12 months after surgery; clinical outcomes including fat mass by bioimpedanciometry were followed up to 24 months. Ordinary Least Squares (OLS) regression was used to evaluate determinants of baseline microbial diversity.
At baseline, patients with severe obesity showed higher microbial Shannon diversity than healthy controls (p = 0.041). The baseline microbiome and metabolome in patients were described as dysfunctional, with a higher Firmicutes/Bacteroidetes ratio and increased levels of branched-chain amino acids (p < 0.0001). These compositional and metabolic differences characterized the obese cohort prior to surgical intervention.
Using OLS regression, the investigators found that adherence to the Mediterranean Diet (PREDIMED score) and presence of type 2 diabetes significantly modulated baseline microbial diversity. The abstract reports these associations but does not provide the full model parameters, effect sizes, or adjustment covariates in the abstract text.
By 12 months post-BS the gut ecosystem underwent substantial remodeling. The study reports a marked depletion of Bifidobacterium spp. and an increase in fecal butyrate levels (p < 0.0001). Rather than returning to a composition similar to healthy controls, the post-surgery microbiome established a novel adaptive state distinct from HC, interpreted as an adaptive restoration rather than true normalization.
A key finding was that baseline gut ecology conditioned long-term surgical outcomes. Patients in the highest quartile of baseline Bifidobacterium abundance lost significantly less fat mass at 24 months compared with those in the lowest quartile: 6.6% versus 13.2% fat-mass loss (p = 0.010). The authors highlight this paradoxical association and characterize high baseline Bifidobacterium as functioning like a “thrifty microbiome” that may enhance energy harvest and thereby limit fat loss induced by surgery.
The study advances the concept that the preoperative gut microbiome can predict long-term adiposity outcomes after bariatric surgery. High baseline Bifidobacterium abundance was associated with reduced fat-mass loss at 24 months and is presented as a candidate “thrifty” microbial phenotype that could attenuate the metabolic benefits of BS. The authors suggest this finding supports exploring precision interventions targeting the microbiome prior to surgery to optimize long-term fat-mass reduction.
Strengths reported in the abstract include a prospective design, serial microbiome and metabolome profiling up to 12 months, and clinical follow-up of fat mass to 24 months. Methods explicitly stated include 16S-rRNA sequencing and 1H-NMR metabolomics, and use of PREDIMED to assess Mediterranean Diet adherence.
Limitations and details not reported in the abstract include the specific bariatric procedures performed, perioperative treatments or antibiotic exposure, full statistical model covariates, adverse-event data, and complete effect-size estimates for all reported associations. The abstract does not provide granular taxonomic or metabolite tables, nor does it report whether findings were independent of changes in caloric intake, physical activity, or other postoperative factors.
In this cohort, baseline gut ecology—particularly high Bifidobacterium abundance—predicted smaller long-term fat mass loss after bariatric surgery, despite broad postoperative microbiome remodeling. The authors frame high baseline Bifidobacterium as a potential “thrifty microbiome” phenotype that may limit surgical weight-loss efficacy and propose that preoperative microbiome-targeted strategies could merit investigation to improve long-term outcomes.
Note: all facts and statistics in this summary are drawn from the PubMed abstract of the cited study. Additional methodological and numerical details beyond the abstract were not reported in the source text provided.